We are monitoring the impact of COVID-19 on MEA Nanomedicine Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 6256
Share on
Share on

Middle East and Africa Nanomedicine Market Research Report - Segmented By Product, Disease Type, Nanomolecule Type & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 6256
Pages: 145

MEA Nanomedicine Market Size (2021 to 2026)

The Middle East and Africa Nanomedicine Market size have been calculated at USD 12.69 billion in 2021. It is projected to grow at a CAGR of 12.9% and be worth USD 23.28 billion by 2026.

The growth of the MEA nanomedicine market is predicted to be encouraged by technological advancements along with relevant applications in early illness diagnosis, preventive intervention, and prophylaxis of chronic and acute disorders. Nanomedicine, which involves the nanoscale development of larger structures and substances, has transformed drug administration. Nanotechnology's ability to serve in both diagnostics and therapeutics simultaneously as a result of its unique principle is expected to boost research in this field. Furthermore, the predicted growth is due to the use of DNA origami in healthcare applications.

The growing prevalence of cancer, genetic and cardiovascular illnesses, increasing advancements in nanoscale technologies for diagnostic processes, and a growing preference for personalized treatments drive the growth of the Middle East and Africa nanotechnology (nanomedicine) industry. Emerging methods for drug delivery, increased use of nanomedicine across various applications, increased government backing and funding, increased demand for therapies with fewer side effects, and cost-effectiveness of therapies are driving the MEA nanomedicine market. One of the key factors driving the market's favorable outlook is the rising prevalence of chronic medical conditions in the region. Oncological, neurological, urological, infectious, ophthalmological, orthopedic, immunological, and cardiovascular illnesses benefit nanomedicine.

An increase in nanomedicine out-licensing and healthcare facilities in this country are expected to help the nanomedicine sector grow. Future expansion is projected to be fueled by the use of nanotechnology-based contrast reagents for diagnosis and monitoring of pharmacological effects on an unprecedentedly short timescale. Demand is also expected to be influenced by the demand for biodegradable implants with extended lifespans that allow for tissue repair. Other growth-inducing aspects include numerous technological developments in nanoscale technologies for improved diagnostic techniques. In addition, nanorobotic systems and other new solutions are being used by pharmaceutical companies to administer nanomedicines effectively.

However, severe regulatory concerns and the high cost of nanoparticle-assisted medicine compared to its traditional competitors are expected to hamper the growth rate of the nanomedicine market in the MEA region. The market's growth is also challenged by the lengthy approval process and the hazards connected with nanomedicine.

This research report on the MEA nanomedicine market has been segmented and sub-segmented into the following categories:

By Product: 

  • Diagnostic Imaging
  • Regenerative Medicine
  • Drug Delivery
  • Implants
  • Vaccines
  • Others

By Disease Type: 

  • Cardiovascular Diseases
  • Neurological Diseases
  • Ophthalmological Diseases
  • Infectious Diseases
  • Immunological Diseases
  • Orthopedic Disorders
  • Oncological Diseases
  • Others

By Nanomolecule Type: 

  • Nanotubes
  • Nanoparticles
  • Nanodevices
  • Nanoshells
  • Others

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Regional Analysis:

The pharmaceutical sector in South Africa can implement nanotechnology, and nanomedicine availability and access should not be a problem. Nanotechnology is a rapidly evolving field of research that deals with the study and manipulation of atomic-scale properties of matter, where the emergence of size-dependent phenomena typically enables novel applications. Nanotechnology research is not cheap, but experts believe that the money spent on it will be beneficial compared to the reductions in treatment expenses and significant improvements in health.

Because of increasingly developing partnerships between companies operating in the region and nanomedicine startup organizations, Africa dominated the MEA nanomedicine industry; the largest portion of the region in the industrial space is attributable to government backing combined with increased R&D spending. South Africa became the first African country to possess a new electron microscopy center to enable the country and Africa to compete with the best in nanoscience and nanotechnology research in the world. South Africa also intends to boost developing advanced manufacturing technologies and R&D-led enterprises to change its industrial base.

KEY MARKET PLAYERS:

A few of the noteworthy companies leading the MEA Nanomedicine Market profiled in the report are Johnson & Johnson, Merck & Co, Pfizer, Abbott Laboratories, GE Healthcare, Celgene Corporation, Nanosphere, Inc, Gilead Sciences, Hoffmann-La Roche, Nanospectra Biosciences, and Arrowhead Pharmaceuticals.

1. Introduction          

                1.1 Market Definition      

                1.2 Study Deliverables    

                1.3 Base Currency, Base Year and Forecast Periods   

                1.4 General Study Assumptions  

2. Research Methodology                    

                2.1 Introduction        

                2.2 Research Phases        

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design  

                2.4 Study Timeline   

3. Overview                

                3.1 Executive Summary  

                3.2 Key Inferences  

                3.3 Epidemology       

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)             

                4.1 Market Drivers   

                4.2 Market Restraints      

                4.3 Key Challenges  

                4.4 Current Opportunities in the Market       

5. Market Segmentation                       

                5.1 Product 

                                5.1.1 Introduction                                           

                                5.1.2 Diagnostic Imaging 

                                5.1.3 Regenerative Medicine                                     

                                5.1.4 Drug Delivery                                         

                                5.1.5 Implants                                   

                                5.1.6 Vaccines                                   

                                5.1.7 Others                                      

                                5.1.8  Y-o-Y Growth Analysis, By Product                                              

                                5.1.9  Market Attractiveness Analysis, By Product                                            

                                5.1.10  Market Share Analysis, By Product                                            

                5.2 Disease Type      

                                5.2.1 Introduction                                           

                                5.2.2 Cardiovascular Diseases                                    

                                5.2.3 Neurological Diseases                                        

                                5.2.4 Ophthalmological Diseases

                                5.2.5 Infectious Diseases                                             

                                5.2.6 Immunological Diseases                                    

                                5.2.7 Orthopedic Disorders                                         

                                5.2.8 Oncological Diseases                                           

                                5.2.9 Others                                      

                                5.2.10 Y-o-Y Growth Analysis, By Disease Type                                  

                                5.2.11 Market Attractiveness Analysis, By Disease Type  

                                5.2.12 Market Share Analysis, By Disease Type                                  

                5.3 Nanomolecule Type        

                                5.3.1 Introduction                                           

                                5.3.2 Nanotubes

                                5.3.3 Nanoparticles                                        

                                5.3.4 Nanodevices                                          

                                5.3.5 Nanoshells

                                5.3.6 Others                                      

                                5.3.7 Y-o-Y Growth Analysis, By Nanomolecule Type                                       

                                5.3.8  Market Attractiveness Analysis, By Nanomolecule Type                                    

                                5.3.9  Market Share Analysis, By Nanomolecule Type                                     

6. Geographical Analysis                       

                6.1 Introduction        

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

  6.1.3.1 By Geographical Area                     

  6.1.3.2 By Product                           

  6.1.3.3 By Disease Type                

  6.1.3.4 By Nanomolecule Type                  

                                6.1.4  Market Attractiveness Analysis                                     

  6.1.4.1 By Geographical Area                     

  6.1.4.2 By Product                           

  6.1.4.3 By Disease Type                

  6.1.4.4 By Nanomolecule Type                  

                                6.1.5  Market Share Analysis                                      

  6.1.5.1 By Geographical Area                     

  6.1.5.2 By Product                           

  6.1.5.3 By Disease Type                

  6.1.5.4 By Nanomolecule Type                  

                6.2 Middle-East         

                6.3 Africa     

7. Strategic Analysis                

                7.1 PESTLE analysis  

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis       

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis                 

                8.1 Johnson & Johnson   

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Merck & Co  

                8.3 Pfizer     

                8.4 Abbott Laboratories        

                8.5 GE Healthcare    

                8.6 Celgene Corporation       

                8.7 Nanosphere, Inc        

                8.8 Gilead Sciences  

                8.9 Hoffmann-La Roche  

                8.10 Nanospectra Biosciences     

                8.11 Arrowhead Pharmaceuticals      

9. Competitive Landscape                    

                9.1 Market share analysis     

                9.2 Merger and Acquisition Analysis

                9.3 Agreements, collaborations and Joint Ventures  

                9.4 New Product Launches  

10. Market Outlook and Investment Opportunities                  

Appendix                    

                a) List of Tables  

                b) List of Figures       

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Product Type, by Disease type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

                                                                                                                          

  1. Middle East and Africa Nanomedicine Market, By Product, From 2021 to 2026 (USD Billion)
  2. Middle East and Africa Diagnostic Imaging Market, By Region, From 2021 to 2026 (USD Billion)
  3. Middle East and Africa Regenerative Medicine Market, By Region, From 2021 to 2026 (USD Billion)
  4. Middle East and Africa Drug Delivery Market, By Region, From 2021 to 2026 (USD Billion)
  5. Middle East and Africa Implants Market, By Region, From 2021 to 2026 (USD Billion)
  6. Middle East and Africa Vaccines Market, By Region, From 2021 to 2026 (USD Billion)
  7. Middle East and Africa Others Market, By Region, From 2021 to 2026 (USD Billion)
  8. Middle East and Africa Nanomedicine Market, By Disease Type, From 2021 to 2026 (USD Billion)
  9. Middle East and Africa Cardiovascular Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  10. Middle East and Africa Neurological Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  11. Middle East and Africa Ophthalmological Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  12. Middle East and Africa Infectious Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  13. Middle East and Africa Immunological Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  14. Middle East and Africa Orthopedic Disorders Market, By Region, From 2021 to 2026 (USD Billion)
  15. Middle East and Africa Oncological Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  16. Middle East and Africa Others Market, By Region, From 2021 to 2026 (USD Billion)
  17. Middle East and Africa Nanomedicine Market, By Nanomolecule Type, From 2021 to 2026 (USD Billion)
  18. Middle East and Africa Nanotubes Market, By Region, From 2021 to 2026 (USD Billion)
  19. Middle East and Africa Nanoparticles Market, By Region, From 2021 to 2026 (USD Billion)
  20. Middle East and Africa Nanodevices Market, By Region, From 2021 to 2026 (USD Billion)
  21. Middle East and Africa Nanoshells  Market, By Region, From 2021 to 2026 (USD Billion)
  22. Middle East and Africa Others Market, By Region, From 2021 to 2026 (USD Billion)
  23. Middle East Nanomedicine Market, By Product, From 2021 to 2026 (USD Billion)
  24. Middle East Nanomedicine Market, By Disease Type, From 2021 to 2026 (USD Billion)
  25. Middle East Nanomedicine Market, By Nanomolecule Type, From 2021 to 2026 (USD Billion)
  26. Africa Nanomedicine Market, By Product, From 2021 to 2026 (USD Billion)
  27. Africa Nanomedicine Market, By Disease Type, From 2021 to 2026 (USD Billion)
  28. Africa Nanomedicine Market, By Nanomolecule Type, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample